Purchases and Sales Made in Q3 2024 in Adagio Therapeutics, Inc. (ADGI)
This table provides information about the institutional ownership of Adagio Therapeutics, Inc. (ADGI) during Q3 2024. The information is specifically focused on institutions that hold shares of Adagio Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-625K- 17.24% |
N/A
|
3M
$9.93M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-666K- 84.69% |
N/A
|
120K
$399K
|
|
|
Nov 14, 2024
Q3 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-698K- 28.75% |
N/A
|
1.73M
$5.72M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-772K- 67.92% |
N/A
|
365K
$1.21M
|